Rational selection of antisense oligonucleotide sequences

European Journal of Pharmaceutical Sciences

Volumn 11, Issue 3, 2000, Pages 191-198

  Smith, Lise ^a   Andersen, Klaus Bahl ^a   Hovgaard, Lars ^a   Jaroszewski, Jerzy W ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antisense oligonucleotides; Antisense selection; Mfold; mRNA secondary structure; mRNA targeting

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY RNA; RIBONUCLEASE H;

COMPUTER ANALYSIS; DNA MICROARRAY; GENE MAPPING; HYBRIDIZATION; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; REVIEW; RNA BINDING; RNA STRUCTURE;

BASE SEQUENCE; DRUG DESIGN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OLIGONUCLEOTIDES, ANTISENSE; RIBONUCLEASE H, CALF THYMUS; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033860727     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(00)00100-7     Document Type: Review

References (32)

1. Akhtar S. Antisense technology: selection and delivery of optimally acting antisense oligonucleotides. J. Drug Targeting. 5:1998;225-234.
2. Bruice T.W., Lima W.F. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA. Biochemistry. 36:1997;5004-5019.
3. Cload S.T., Schepartz A. Selection of structure-specific inhibitors of the HIV Rev-Rev response element complex. J. Am. Chem. Soc. 116:1994;437-442.
4. Crooke S.T. Molecular mechanism of action of oligonucleotides designed to interact with nucleic acids. Crooke S.T. Therapeutic Applications of Oligonucleotides. 1995;11-38 R.G. Landes, Austin.
5. Crooke S.T. The selection of optimal RNA receptor sites for antisense effects. Crooke S.T. Therapeutic Applications of Oligonucleotides. 1995;39-52 R.G. Landes, Austin.
6. Han J., Zhu Z., Hsu C., Finley W.H. Selection of antisense oligonucleotides on the basis of genomic frequency of the target sequence. Antisense Res. Dev. 4:1994;53-65.
7. Ho S.P., Britton D.H., Stone B.A., Behrens D.L., Leffet L.M., Hobbs F.W., Miller J.A., Trainor G.L. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res. 24:1996;1901-1907.
8. Ho S.P., Bao Y.J., Lesher T., Malhotra R., Ma L.Y., Fluharty S.J., Sakai R.R. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries. Nat. Biotechnol. 16:1998;59-63.
9. Jaroszewski J.W. Antisense drugs. Frøkjær S., Christrup L., Krogsgaard-Larsen P. Peptide and Protein Drug Delivery. Alfred Benzon Symposium. Vol. 43:1998;452-458 Munksgaard, Copenhagen.
10. Jaroszewski J.W., Syi J.L., Ghosh M., Ghosh K., Cohen J.S. Targeting of antisense DNA: comparison of activity of anti-rabbit β-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding. Antisense Res. Dev. 3:1993;339-348.
11. Kandimalla E.R., Agrawal S. Single-strand-targeted triplex formation: stability, specificity and RNase H activation properties. Gene. 149:1994;115-121.
12. Le Novère, 2000. Melting4, http://www.pasteur.fr/unites/neubiomol/meltinghome.html.
13. Le Tinévez R., Mishra R.K., Toulmé J.J. Selective inhibition of cell-free translation by oligonucleotides targeted to a mRNA hairpin structure. Nucleic Acids Res. 26:1998;2273-2278.
14. Lima W.F., Monia B.P., Ecker D.J., Freier S.M. Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry. 31:1992;12055-12061.
15. Lima W.F., Brown Driver V., Fox M., Hanecak R., Bruice T.W. Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J. Biol. Chem. 272:1997;626-638.
16. Mathews D.H., Sabina J., Zuker M., Turner D.H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288:1999;911-940.
17. Matveeva O., Felden B., Audlin S., Gesteland R.F., Atkins J.F. A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures. Nucleic Acids Res. 25:1997;5010-5016.
18. Milner N., Mir K.U., Southern E.M. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat. Biotechnol. 15:1997;537-541.
19. Mishra R.K., Toulmé J.J. In vitro selection of antisense oligonucleotides targeted to a hairpin structure. CR Acad. Sci. III. 317:1994;977-982.
20. Mishra R.K., Le Tinevez R., Toulmé J.J. Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection. Proc. Natl. Acad. Sci. USA. 93:1996;10679-10684.
21. Mitsuhashi M., Cooper A., Ogura M., Shinagawa T., Yano K., Hosokawa T. Oligonucleotide probe design - a new approach. Nature. 367:1994;759-761.
22. Monia B.P., Johnston J.F., Geiger T., Muller M., Fabbro D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat. Med. 2:1996;668-675.
23. Patzel V., Sczakiel G. Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells. Nat. Biotechnol. 16:1998;64-68.
24. Patzel V., Putlitz J.Z., Wieland S., Blum H.E., Sczakiel G. Theoretical and experimental selection parameters for HBV-directed antisense RNA are related to increased RNA-RNA annealing. Biol. Chem. 378:1997;539-543.
25. Pavlakis G.N., Lockard R.E., Vamvakopoulos N., Rieser L., RajBhandary U.L., Vournakis J.N. Secondary structure of mouse and rabbit a- and b-globin mRNAs: differential accessibility of α and β initiator AUG codons towards nucleases. Cell. 19:1980;91-102.
26. Sczakiel G., Homann M., Rittner K. Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res. Dev. 3:1993;45-52.
27. Sohail M., Akhtar S., Southern E.M. The folding of large RNAs studied by hybridization to arrays of complementary oligonucleotides. RNA. 5:1999;646-655.
28. Southern E.M., Case Green S.C., Elder J.K., Johnson M., Mir K.U., Wang L., Williams J.C. Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids. Nucleic Acids Res. 22:1994;1368-1373.
29. Tu G.C., Cao Q.N., Zhou F., Israel Y. Tetranucleotide GGGA motif in primary RNA transcripts. Novel target site for antisense design. J. Biol. Chem. 273:1998;25125-25131.
30. Uhlmann E., Peyman A. Antisense oligonucleotides: a new principle. Chem. Rev. 90:1990;543-584.
31. Zuker M., Jacobson A.B. 'Well-determined' regions in RNA secondary structure prediction: analysis of small subunit ribosomal RNA. Nucleic Acids Res. 23:1995;2791-2798.
32. Zuker M., Mathews D.H., Turner D.H. Algorithms and thermodynamics for RNA secondary structure prediction: a practical guide. Barciszewski J., Clark B.F.C. RNA Biochemistry and Biotechnology. 1999;Kluwer Academic, Dordrecht.